K. Luijtens
K. Luijtens publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Biosimilars and Bioanalytical Methods.
- World rank
- #3,211,245 of 7,710,434 ranked researchers
- Rank in Belgium
- #29,071 of 67,186
- Works
- 35
- Citations
- 1.2k
- Citations per work
- 32.9
What does K. Luijtens research?
K. Luijtens's work is mostly in Medicine (62%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2261.6%
- Medicine2261.6%
- Everything else1028.5%
- Life Sciences39.9%
- 1Rheumatology47% of their works
- 2Immunology10% of their works
- 3Hematology4% of their works
- 4Pathology and Forensic Medicine3% of their works
- 5Pulmonary and Respiratory Medicine3% of their works
- 6Genetics3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Biosimilars and Bioanalytical Methods
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Chronic Lymphocytic Leukemia Research
- Pregnancy and Medication Impact
- Peripheral Neuropathies and Disorders
Which keywords describe K. Luijtens's research?
The keywords of their largest research topics: Autoantibodies, Rheumatoid Arthritis, Biological Therapy, Inflammation, Ankylosing Spondylitis, Spondyloarthritis, Antiphospholipid Syndrome and Biosimilars.
- Guillain-Barré Syndrome
- Pregnancy
- Genomic Aberrations
- Juvenile Idiopathic Arthritis
- Systemic Lupus Erythematosus
- Biosimilars
- Spondyloarthritis
- Inflammation
- Rheumatoid Arthritis
- Autoantibodies
- Biological Therapy
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Immunogenicity
- Hemophagocytic Lymphohistiocytosis
- Chronic Lymphocytic Leukemia
- Medication Use
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Autoantibodies302 topics
- Rheumatoid Arthritis262 topics
- Biological Therapy231 topic
- Inflammation231 topic
- Ankylosing Spondylitis131 topic
- Spondyloarthritis131 topic
- Antiphospholipid Syndrome71 topic
- Biosimilars71 topic
- Immunogenicity71 topic
- Systemic Lupus Erythematosus71 topic
- Hemophagocytic Lymphohistiocytosis41 topic
- Juvenile Idiopathic Arthritis41 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- Medication Use31 topic
- Pregnancy31 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy21 topic
- Guillain-Barré Syndrome21 topic
Where does K. Luijtens work?
K. Luijtens's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does K. Luijtens have?
OpenAlex counts 35 works and 1,153 citations for K. Luijtens, an h-index of 11, ranking #3,211,245 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about K. Luijtens. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.